jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Journal of Pharmacology and PharmacotherapeuticsNOW IN
Article

Recurrence of atrial fibrillation after switching from brand to generic atenolol

Luca Gallelli1★, Francesca Maida1, Orietta Staltari1, Pierandrea Rende1, Emilio Russo1, Benedetto Caroleo1★ Corresponding author

  1. 1Giovambattista De Sarro Department of Health Science, University of Catanzaro, Catanzaro, Italy.

CORRESPONDENCE

Luca Gallelli

Giovambattista De Sarro Department of Health Science, University of Catanzaro, Catanzaro, Italy.

gallelli@unicz.it

Received: 23-01-2014; Revised: 31-05-2014; Accepted: 28-06-2014.

Volume 6, Issue 1 · pp. 158–160 · PUBLISHED 2014 · DOI: 10.4103/0976-500X.149146

View on JPP original site ↗

ABSTRACT

Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Gallelli, L., Maida, F., Staltari, O., Rende, P., Russo, E., & Caroleo, B. (2014). Recurrence of atrial fibrillation after switching from brand to generic atenolol. Journal of Pharmacology and Pharmacotherapeutics, 6(1), 158–160. https://doi.org/10.4103/0976-500X.149146